Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Northrup

Showing results (591-600 of 803) with videos related to

Pageof 81
Sort By:
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitisJoshua O Sestak, Bradley P Sullivan, Sharadvi Thati, et al.
Journal of the American Veterinary Medical Association|January 4, 2019
Substitution of mitoxantrone for doxorubicin in a multidrug chemotherapeutic protocol for first-line treatment of dogs with multicentric intermediate- to large-cell lymphomaTaya M Marquardt, Stephanie E S Lindley, Annette N Smith, et al.
Ecology Letters|March 14, 2026
Top-Down and Bottom-Up Processes Jointly Explain Mesopredator Movement and Foraging EcologyKatie R N Florko, Tyler R Ross, Steven H Ferguson, et al.
Pediatric Neurology|October 4, 2020
Epilepsy Risk Prediction Model for Patients With Tuberous Sclerosis ComplexLaura S Farach, Melissa A Richard, Philip J Lupo, et al.
Nature Genetics|September 1, 1992
Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney diseaseR S Kandt, J L Haines, M Smith, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
Determinants of individual variation in intracellular accumulation of anti-HIV nucleoside analog metabolitesElijah Paintsil, Ginger E Dutschman, Rong Hu, et al.
Nature Immunology|January 8, 2008
Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5Jagan M R Pongubala, Daniel L Northrup, David W Lancki, et al.
American Journal of Human Genetics|October 11, 1992
Evidence for genetic heterogeneity in tuberous sclerosis: one locus on chromosome 9 and at least one locus elsewhereH Northrup, D J Kwiatkowski, E S Roach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemiaNina S Kadan-Lottick, Pim Brouwers, David Breiger, et al.
Research Square|July 10, 2026
The impact of nationwide folic acid fortification on genetic variants associated with conotruncal heart defectsSarah U Morton, Enrique Mondragon-Estrada, Rui Qian, et al.
Pageof 81

Showing results (591-600 of 803) with videos related to

Sort By:
Pageof 81
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitisJoshua O Sestak, Bradley P Sullivan, Sharadvi Thati, et al.
Journal of the American Veterinary Medical Association|January 4, 2019
Substitution of mitoxantrone for doxorubicin in a multidrug chemotherapeutic protocol for first-line treatment of dogs with multicentric intermediate- to large-cell lymphomaTaya M Marquardt, Stephanie E S Lindley, Annette N Smith, et al.
Ecology Letters|March 14, 2026
Top-Down and Bottom-Up Processes Jointly Explain Mesopredator Movement and Foraging EcologyKatie R N Florko, Tyler R Ross, Steven H Ferguson, et al.
Pediatric Neurology|October 4, 2020
Epilepsy Risk Prediction Model for Patients With Tuberous Sclerosis ComplexLaura S Farach, Melissa A Richard, Philip J Lupo, et al.
Nature Genetics|September 1, 1992
Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney diseaseR S Kandt, J L Haines, M Smith, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
Determinants of individual variation in intracellular accumulation of anti-HIV nucleoside analog metabolitesElijah Paintsil, Ginger E Dutschman, Rong Hu, et al.
Nature Immunology|January 8, 2008
Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5Jagan M R Pongubala, Daniel L Northrup, David W Lancki, et al.
American Journal of Human Genetics|October 11, 1992
Evidence for genetic heterogeneity in tuberous sclerosis: one locus on chromosome 9 and at least one locus elsewhereH Northrup, D J Kwiatkowski, E S Roach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemiaNina S Kadan-Lottick, Pim Brouwers, David Breiger, et al.
Research Square|July 10, 2026
The impact of nationwide folic acid fortification on genetic variants associated with conotruncal heart defectsSarah U Morton, Enrique Mondragon-Estrada, Rui Qian, et al.
Pageof 81